Overview

Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
ALB-TRIAL
Phase:
Phase 4
Details
Lead Sponsor:
Aleksander Krag
Collaborator:
EASL - CLIF Consortium